FDA Approves New 2-Drug Combo Medicine for Asthma
THURSDAY, Jan. 12, 2023 (HealthDay News) — Adults with asthma now have a new rescue medication to turn to after the U.S. Food and Drug Administration approved Airsupra on Wednesday. The drug is the first approved to combine albuterol (a beta-2 adrenergic agonist) and budesonide (a corticosteroid). It’s meant forContinue Reading